COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections

COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections

Background: To determine the effect of disease-modifying therapies (DMT) on humoral postvaccine seroconversion, long-term humoral response, and breakthrough COVID-19 infections in persons with multiple sclerosis (PwMS) and other neuroinflammatory disorders. Methods: A total of 757 PwMS and other neu...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Dejan Jakimovski, Karen Zakalik, Samreen Awan, Katelyn S. Kavak, Penny Pennington, David Hojnacki, Channa Kolb, Alexis A. Lizarraga, Svetlana P. Eckert, Rosila Sarrosa, Kamath Vineetha, Keith Edwards, Bianca Weinstock-Guttman
פורמט: Article
שפה:English
יצא לאור: MDPI AG 2022-04-01
סדרה:Vaccines
נושאים:
COVID-19
SARS-CoV-2 vaccination
BNT162b2
mRNA-1273
Ad26.COV2.S
breakthrough infection
גישה מקוונת:https://www.mdpi.com/2076-393X/10/5/695

אינטרנט

https://www.mdpi.com/2076-393X/10/5/695

פריטים דומים